Taysha Gene Therapies Inc (TSHA) earnings · rev $9.8M
These earnings events as JSON? API free 100/dayTaysha Gene Therapies Inc (TSHA) is a biotechnology company listed on US.
This TSHA earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported TSHA revenue for 2025-12-31 was $9.8M. Net income was -$109.0M. Revenue was up 17.3% from 2024-12-31 to 2025-12-31. TSHA currently screens at market cap $640.7M.
When the next TSHA 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 17.3% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full TSHA research stays on the stock page; the tape stays on the quote page.
TSHA earnings FAQ
What are TSHA's latest revenue and net income?
Latest cached Taysha Gene Therapies Inc (TSHA) revenue for Dec 31, 2025 was $9.8M. Net income was -$109.0M. Statements: https://lician.com/financials/tsha
What is TSHA's latest diluted EPS?
Latest cached Taysha Gene Therapies Inc (TSHA) diluted EPS for Dec 31, 2025 was -$0.34.
What period does the latest TSHA earnings print cover?
The latest cached Taysha Gene Therapies Inc (TSHA) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did TSHA revenue change from the prior cached period?
Cached Taysha Gene Therapies Inc (TSHA) revenue was up 17.3% from $8.3M (Dec 31, 2024) to $9.8M (Dec 31, 2025). Statements: https://lician.com/financials/tsha
Where are TSHA earnings listed?
Cached earnings facts for Taysha Gene Therapies Inc (TSHA) are listed at https://lician.com/earnings/tsha. Statements: https://lician.com/financials/tsha
Not investment advice.